Chemotherapy Combined With Radiation Therapy for Newly Diagnosed CNS AT/RT

Completed · Phase 2

Conditions studied: Central Nervous System Tumor, Pediatric

In brief

RATIONALE: Drugs used in chemotherapy work in different ways to stop tumor cells from dividing so they stop growing or die. Radiation therapy uses high-energy x-rays to damage tumor cells. Giving more than one chemotherapy drug with radiation therapy may kill more tumor cells. PURPOSE: This phase II trial is studying how well giving intrathecal and systemic combination chemotherapy together with radiation therapy works in treating young patients with newly diagnosed central nervous system (CNS) atypical teratoid/rhabdoid tumors.

Key facts

Study ID
NCT00084838
Run by
Dana-Farber Cancer Institute
People needed
25
Starts
2003-02-01
Expected to finish
2013-03-01
Last updated by the study team
2015-12-24

Who can join

Age: any, up to 18. Sex: any. Healthy volunteers: not accepted.

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.